Rheumatology and Immunology Department, The First Hospital of Nanchang, No. 128, North Xiangshan Road, Nanchang, 330008, Jiangxi Province, China.
Tissue Eng Regen Med. 2024 Dec;21(8):1203-1216. doi: 10.1007/s13770-024-00668-8. Epub 2024 Oct 3.
Osteoarthritis (OA), a degenerative joint disorder, is a major reason of disability in adults. Accumulating evidences have proved that bone marrow mesenchymal stem cells (BMSCs)-carried exosomes play a significant therapeutic effect on OA. However, the precise regulatory network remains unknown.
OA and normal cartilage samples were acquired from patients, and chondrocytes were exposed to IL-1β to conduct a cellular OA model. Exosomes prepared from BMSCs were identified using nanoparticle tracking analysis (NTA) and transmission electron microscopy (TEM). Cell viability was determined with CCK-8 assay. Inflammatory injury was assessed by LDH and inflammatory factors (TNF-α and IL-6) using corresponding ELISA kits, respectively. Ferroptosis was evaluated by GSH, MDA and iron levels using corresponding kits, and ROS level with DCFH-DA. The expressions of genes/proteins were determined with RT-qPCR/western bolt. RNA immunoprecipitation and luciferase activity assay were conducted for testing the interactions of small nucleolar RNA host gene 7 (SNHG7)/ferroptosis suppressor protein 1 (FSP1) and miR-485-5p.
The expressions of SNHG7 and FSP1 were both reduced in IL-1β-induced chondrocytes and OA cartilage tissues, and there was a positive correlation between them in clinical level. Moreover, SNHG7 was enriched in BMSCs-derived exosomes (BMSCs-Exos) and could be internalized by chondrocytes. Functional analysis illustrated that BMSCs-Exos administration repressed inflammatory injury, oxidative stress and ferroptosis in IL-1β-induced chondrocytes, while these changes were reinforced when SNHG7 was overexpressed in BMSCs-Exos. Notably, FSP1 silencing in chondrocytes abolished the beneficial effects mediated by exosomal SNHG7.
Exosomal SNHG7 released from BMSCs inhibited inflammation and ferroptosis in IL-1β-induced chondrocytes through miR-485-5p/FSP1 axis. This work suggested that BMSCs-derived exosomal SNHG7 would be a prospective target for OA treatment.
骨关节炎(OA)是一种退行性关节疾病,是成年人残疾的主要原因。越来越多的证据证明骨髓间充质干细胞(BMSCs)来源的细胞外囊泡对 OA 具有显著的治疗作用。然而,确切的调控网络尚不清楚。
从患者中获取 OA 和正常软骨样本,并将软骨细胞暴露于 IL-1β 中构建细胞 OA 模型。使用纳米颗粒跟踪分析(NTA)和透射电子显微镜(TEM)鉴定 BMSCs 来源的细胞外囊泡。通过 CCK-8 测定法测定细胞活力。分别使用相应的 ELISA 试剂盒测定 LDH 和炎性因子(TNF-α 和 IL-6)评估炎性损伤。使用相应试剂盒测定 GSH、MDA 和铁水平评估铁死亡,并用 DCFH-DA 测定 ROS 水平。通过 RT-qPCR/western bolt 测定基因/蛋白的表达。通过 RNA 免疫沉淀和荧光素酶活性测定进行小核仁 RNA 宿主基因 7(SNHG7)/铁死亡抑制蛋白 1(FSP1)和 miR-485-5p 相互作用的检测。
在 IL-1β 诱导的软骨细胞和 OA 软骨组织中,SNHG7 和 FSP1 的表达均降低,且在临床水平上呈正相关。此外,SNHG7 在 BMSCs 来源的细胞外囊泡(BMSCs-Exos)中富集,并可被软骨细胞内化。功能分析表明,BMSCs-Exos 给药抑制了 IL-1β 诱导的软骨细胞的炎症损伤、氧化应激和铁死亡,而当 BMSCs-Exos 中 SNHG7 过表达时,这些变化得到增强。值得注意的是,在软骨细胞中沉默 FSP1 消除了外泌体 SNHG7 介导的有益作用。
BMSCs 释放的细胞外囊泡 SNHG7 通过 miR-485-5p/FSP1 轴抑制 IL-1β 诱导的软骨细胞中的炎症和铁死亡。这项工作表明,BMSCs 来源的细胞外囊泡 SNHG7 可能成为 OA 治疗的一个有前景的靶点。